Premium
P2‐013: CSF biomarkers and disease progression in an interrupted MCI trial
Author(s) -
Peters Oliver,
Joachim Lisa Katharina,
Schmidtke Klaus,
Hüll Michael,
Rüther Eckart,
Teipel Stefan,
Möller HansJürgen,
Jessen Frank,
Luckhaus Christian,
Maier Wolfgang,
Wiltfang Jens,
Kornhuber Johannes,
Frolich Lutz,
Heuser Isabella
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2012.05.716
Subject(s) - memantine , galantamine , medicine , placebo , dementia , clinical trial , donepezil , randomized controlled trial , disease , pathology , alternative medicine
Oliver Peters, Lisa Katharina Joachim, Klaus Schmidtke, Michael H€ull, Eckart R€uther, Stefan Teipel, Hans-J€urgen M€oller, Frank Jessen, Christian Luckhaus, Wolfgang Maier, Jens Wiltfang, Johannes Kornhuber, Lutz Frolich, Isabella Heuser, Charit e, Berlin, Germany; 2 Klinikum Ortenau, Offenburg, Germany; 3 University of Freiburg ZGGF, Freiburg, Germany; LMU Munich, Munich, Germany; Department of Psychiatry, University of Rostock, Rostock, Germany; 6 LMU Munich, Munich, Germany; 7 University Bonn, Bonn, Germany; 8 University D€usseldorf, D€usseldorf, Germany; 9 University of Duisburg-Essen, Essen, Germany; University Erlangen, Erlangen, Germany; CIMH, Mannheim, Germany.